Eytan or called Apatinib Mesylate Tablets, which is indicated for the treatment of advanced gastric cancer anti-tumor angiogenesis, was developed among the third-line treatment of gastric cancer, and it is now considered that the drug can also be used for primary liver cancer, lung cancer, soft tissue sarcoma and other tumors. The main purpose is anti-tumor angiogenesis vascular, vascular renormalization, which can be used in combination with radiotherapy and chemotherapy to help improve the effect of local control of tumor, improve the sensitivity of radiotherapy and other effects. The main side effects are causing side effects such as hypertension, proteinuria and bleeding. Comparing its side effects, the benefits brought by the treatment outweigh the side effects. If there is an indication for using Apatinib Mesylate Tablets, you can boldly use this drug and the side effects of the drug are relatively mild.